{"id":"NCT02680574","sponsor":"Akebia Therapeutics","briefTitle":"Efficacy and Safety Study to Evaluate Vadadustat for the Maintenance Treatment of Anemia in Participants With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)","officialTitle":"Phase 3, Randomized, Open-label, Active-controlled Study Evaluating the Efficacy and Safety of Oral Vadadustat for the Maintenance Treatment of Anemia in Subjects With Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD) (PRO2TECT-CONVERSION)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2016-02","primaryCompletion":"2020-06-18","completion":"2020-07-31","firstPosted":"2016-02-11","resultsPosted":"2022-06-27","lastUpdate":"2022-06-27"},"enrollment":1725,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Anemia","Non-Dialysis-Dependent Chronic Kidney Disease"],"interventions":[{"type":"DRUG","name":"Vadadustat","otherNames":["AKB-6548"]},{"type":"DRUG","name":"Darbepoetin alfa","otherNames":["Aranesp"]}],"arms":[{"label":"Vadadustat","type":"EXPERIMENTAL"},{"label":"Darbepoetin alfa","type":"ACTIVE_COMPARATOR"}],"summary":"A multicenter, randomized, open-label, active-controlled Phase 3 study for the maintenance treatment of anemia in participants with Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)","primaryOutcome":{"measure":"Change From Baseline in Hemoglobin (Hb) to the Average Over the Primary Efficacy Period (Weeks 24 to 36)","timeFrame":"Baseline; Weeks 24 to 36","effectByArm":[{"arm":"Vadadustat","deltaMin":0.41,"sd":0.036},{"arm":"Darbepoetin Alfa","deltaMin":0.42,"sd":0.037}],"pValues":[{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":6},"locations":{"siteCount":503,"countries":["United States","Argentina","Australia","Austria","Brazil","Bulgaria","Canada","Chile","Colombia","Czechia","France","Germany","Hungary","Israel","Italy","Malaysia","Mexico","New Zealand","Poland","Puerto Rico","Romania","Russia","Serbia","Slovakia","South Africa","South Korea","Spain","Turkey (TÃ¼rkiye)","Ukraine","United Kingdom"]},"refs":{"pmids":["40359056","37427292","36005278","33913637"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":504,"n":861},"commonTop":["Hypertension","Urinary tract infection","Diarrhoea","Oedema peripheral","Hyperkalaemia"]}}